Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy

References

• Zhao X, Di Q, Yu J, et al. USP19 (ubiquitin specific peptidase 19) promotes TBK1 (TANK-binding kinase 1) degradation via chaperone-mediated autophagy. Autophagy. 2022 Apr;18(4):891–908. doi: 10.1080/15548627.2021.1963155
   PubMed Web of Science ®Google Scholar
• Ktistakis NT, Tooze SA. Digesting the expanding mechanisms of autophagy. Trends Cell Biol. 2016 Aug;26(8):624–635. doi: 10.1016/j.tcb.2016.03.006
   PubMed Web of Science ®Google Scholar
• Shibutani ST, Saitoh T, Nowag H, et al. Autophagy and autophagy-related proteins in the immune system. Nat Immunol. 2015 Oct;16(10):1014–1024. doi: 10.1038/ni.3273
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011 Nov 11;147(4):728–741. doi: 10.1016/j.cell.2011.10.026
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019 Jan 10;176(1–2):11–42. doi: 10.1016/j.cell.2018.09.048
   PubMed Web of Science ®Google Scholar
• Vo TP, Ho GWK, Andrea J. Achilles tendinopathy, a brief review and update of current literature. Curr Sports Med Rep. 2021 Sep 1;20(9):453–461. doi: 10.1249/JSR.0000000000000884
   PubMed Web of Science ®Google Scholar
• Lui PPY, Wong CM. Biology of tendon stem cells and tendon in Aging. Front Genet. 2019;10:1338. doi: 10.3389/fgene.2019.01338
   PubMed Web of Science ®Google Scholar
• Oudelaar BW, Huis in ‘t Veld R, Ooms EM, et al. Efficacy of adjuvant application of platelet-rich plasma after needle aspiration of calcific deposits for the treatment of rotator cuff calcific tendinitis: a double-blinded, randomized controlled trial with 2-year follow-up. Am J Sports Med. 2021 Mar;49(4):873–882. doi: 10.1177/0363546520987579
   PubMed Web of Science ®Google Scholar
• Kim RJ, Hah YS, Sung CM, et al. Do antioxidants inhibit oxidative-stress-induced autophagy of tenofibroblasts? J Orthop Res. 2014 Jul;32(7):937–943. doi: 10.1002/jor.22608
   PubMed Web of Science ®Google Scholar
• Montagna C, Svensson RB, Bayer ML, et al. Autophagy guards tendon homeostasis. Cell Death Dis. 2022 Apr 23;13(4):402. doi: 10.1038/s41419-022-04824-7
   PubMed Web of Science ®Google Scholar
• Li K, Deng Y, Deng G, et al. High cholesterol induces apoptosis and autophagy through the ROS-activated AKT/FOXO1 pathway in tendon-derived stem cells. Stem Cell Res Ther. 2020 Mar 20;11(1):131. doi: 10.1186/s13287-020-01643-5
   PubMed Web of Science ®Google Scholar
• Chen H, Ge HA, Wu GB, et al. Autophagy prevents oxidative stress-induced loss of self-renewal capacity and stemness in human tendon stem cells by reducing ROS accumulation. Cell Physiol Biochem. 2016;39(6):2227–2238. doi: 10.1159/000447916
   PubMedGoogle Scholar
• Semis HS, Gur C, Ileriturk M, et al. Evaluation of therapeutic effects of quercetin against achilles tendinopathy in rats via oxidative stress, inflammation, apoptosis, autophagy, and metalloproteinases. Am J Sports Med. 2022 Feb;50(2):486–498. doi: 10.1177/03635465211059821
   PubMed Web of Science ®Google Scholar
• Zheng W, Qian Y, Chen S, et al. Rapamycin protects against peritendinous fibrosis through activation of autophagy. Front Pharmacol. 2018;9:402. doi: 10.3389/fphar.2018.00402
   PubMed Web of Science ®Google Scholar
• Xu L, Xu K, Wu Z, et al. Pioglitazone attenuates advanced glycation end products-induced apoptosis and calcification by modulating autophagy in tendon-derived stem cells. J Cell Mol Med. 2020 Feb;24(3):2240–2251. doi: 10.1111/jcmm.14901
   PubMed Web of Science ®Google Scholar
• Vainshtein A, Grumati P. Selective autophagy by close encounters of the ubiquitin kind. Cells. 2020 Oct 24;9(11):2349. doi: 10.3390/cells9112349
   PubMed Web of Science ®Google Scholar
• Yao RQ, Ren C, Xia ZF, et al. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. Autophagy. 2021 Feb;17(2):385–401. doi: 10.1080/15548627.2020.1725377
   PubMed Web of Science ®Google Scholar
• Miao XD, Jiang H, Wu YP, et al. Treatment of calcified insertional achilles tendinopathy by the posterior midline approach. J Foot Ankle Surg. 2016 May-Jun;55(3):529–534. doi: 10.1053/j.jfas.2016.01.016
   PubMed Web of Science ®Google Scholar
• Louwerens JKG, Alkaduhimi H, van den Bekerom MPJ. Association between rotator cuff tears and calcific tendinopathy. Arthrosc: J Arthrosc Relat Surg. 2020 Mar;36(3):625–626. doi: 10.1016/j.arthro.2020.01.007
   PubMed Web of Science ®Google Scholar
• De Zordo T, Ahmad N, Odegaard F, et al. US-guided therapy of calcific tendinopathy: clinical and radiological outcome assessment in shoulder and non-shoulder tendons. Ultraschall Med. 2011 Jan;32(1):S117–23. doi: 10.1055/s-0029-1245333
   PubMedGoogle Scholar
• Wu Y, Qian J, Li K, et al. Farrerol alleviates collagenase-induced tendinopathy by inhibiting ferroptosis in rats. J Cell Mol Med. 2022 Jun;26(12):3483–3494. doi: 10.1111/jcmm.17388
   PubMed Web of Science ®Google Scholar
• Jiang H, Lin X, Liang W, et al. Friedelin alleviates the pathogenesis of collagenase-induced tendinopathy in mice by promoting the selective autophagic degradation of p65. Nutrients. 2022 Apr 18;14(8):1673. doi: 10.3390/nu14081673
   PubMed Web of Science ®Google Scholar
• Ames PR, Longo UG, Denaro V, et al. Achilles tendon problems: not just an orthopaedic issue. Disabil Rehabil. 2008;30(20–22):1646–1650. doi: 10.1080/09638280701785882
   PubMed Web of Science ®Google Scholar
• Hreljac A. Etiology, prevention, and early intervention of overuse injuries in runners: a biomechanical perspective. Phys Med Rehabil Clin N Am. 2005 Aug;16(3):651–667. vi. doi: 10.1016/j.pmr.2005.02.002
   PubMedGoogle Scholar
• Dilger CP, Chimenti RL. Nonsurgical treatment options for insertional achilles tendinopathy. Foot Ankle Clin. 2019 Sep;24(3):505–513. doi: 10.1016/j.fcl.2019.04.004
   PubMed Web of Science ®Google Scholar
• Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061–1075. doi: 10.2147/TCRM.S79135
   PubMed Web of Science ®Google Scholar
• Ranganathan K, Loder S, Agarwal S, et al. Heterotopic ossification: basic-science principles and clinical correlates. J Bone Joint Surg Am. 2015 Jul 1;97(13):1101–1111. doi: 10.2106/JBJS.N.01056
   PubMedGoogle Scholar
• D’Addona A, Maffulli N, Formisano S, et al. Inflammation in tendinopathy. Surgeon. 2017 Oct;15(5):297–302. doi: 10.1016/j.surge.2017.04.004
   PubMed Web of Science ®Google Scholar
• Sunwoo JY, Eliasberg CD, Carballo CB, et al. The role of the macrophage in tendinopathy and tendon healing. J Orthop Res. 2020 Aug;38(8):1666–1675. doi: 10.1002/jor.24667
   PubMed Web of Science ®Google Scholar
• Wang Y, He G, Tang H, et al. Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway. Cell Prolif. 2019 Jul;52(4):e12650. doi: 10.1111/cpr.12650
   PubMed Web of Science ®Google Scholar
• Jo CH, Lee SY, Yoon KS, et al. Effects of platelet-rich plasma with concomitant use of a corticosteroid on tenocytes from degenerative rotator cuff tears in interleukin 1beta-induced tendinopathic conditions. Am J Sports Med. 2017 Apr;45(5):1141–1150. doi: 10.1177/0363546516681294
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Wanderer AA. Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep. 2010 Jul;10(4):229–235. doi: 10.1007/s11882-010-0109-z
   PubMed Web of Science ®Google Scholar
• Vinhas A, Rodrigues MT, Goncalves AI, et al. Magnetic responsive materials modulate the inflammatory profile of IL-1beta conditioned tendon cells. Acta Biomater. 2020 Nov;117:235–245.
   PubMed Web of Science ®Google Scholar
• Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance. J Cell Sci. 2017 Dec 1;130(23):3955–3963. doi: 10.1242/jcs.207365
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhou J, Zhang B, et al. Cyclic stretching exacerbates tendinitis by enhancing NLRP3 inflammasome activity via F-Actin depolymerization. Inflammation. 2018 Oct;41(5):1731–1743. doi: 10.1007/s10753-018-0816-5
   PubMed Web of Science ®Google Scholar
• Wang B, Tian Y, Yin Q. AIM2 inflammasome assembly and signaling. Adv Exp Med Biol. 2019;1172:143–155.
   PubMed Web of Science ®Google Scholar
• Lugrin J, Martinon F. The AIM2 inflammasome: Sensor of pathogens and cellular perturbations. Immunol Rev. 2018 Jan;281(1):99–114. doi: 10.1111/imr.12618
   PubMed Web of Science ®Google Scholar
• Petronelli A, Pannitteri G, Testa U. Triterpenoids as new promising anticancer drugs. Anticancer Drugs. 2009 Nov;20(10):880–892. doi: 10.1097/CAD.0b013e328330fd90
   PubMed Web of Science ®Google Scholar
• Yousef BA, Hassan HM, Zhang LY, et al. Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-small ka, CyrillicB signaling pathway in colorectal cancer cells. Phytomedicine. 2018 Feb 1;40:140–147. doi: 10.1016/j.phymed.2018.01.008
   PubMed Web of Science ®Google Scholar
• Vasileiadis GI, Sioutis IC, Mavrogenis AF, et al. COX-2 inhibitors for the prevention of heterotopic ossification after THA. Orthopedics. 2011 Jun;34(6):467. doi: 10.3928/01477447-20110427-23
   PubMed Web of Science ®Google Scholar
• Sun Z, Li J, Luo G, et al. Pharmacological activation of SIRT1 by metformin prevented trauma-induced heterotopic ossification through inhibiting macrophage mediated inflammation. Eur J Pharmacol. 2021 Oct 15;909:174386. doi: 10.1016/j.ejphar.2021.174386
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019 Jul 6;20(13):3328. doi: 10.3390/ijms20133328
   PubMed Web of Science ®Google Scholar
• Zhao Q, Bi Y, Guo J, et al. Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation. Acta Pharmacol Sin. 2021 Jun;42(6):975–986. doi: 10.1038/s41401-020-00527-x
   PubMed Web of Science ®Google Scholar
• Lian O, Scott A, Engebretsen L, et al. Excessive apoptosis in patellar tendinopathy in athletes. Am J Sports Med. 2007 Apr;35(4):605–611. doi: 10.1177/0363546506295702
   PubMed Web of Science ®Google Scholar
• Benson RT, McDonnell SM, Knowles HJ, et al. Tendinopathy and tears of the rotator cuff are associated with hypoxia and apoptosis. J Bone Joint Surg Br. 2010 Mar;92(3):448–453. doi: 10.1302/0301-620X.92B3.23074
   PubMedGoogle Scholar
• Liu T, Tang Q, Liu K, et al. TRIM11 suppresses AIM2 inflammasome by degrading AIM2 via p62-dependent selective autophagy. Cell Rep. 2016 Aug 16;16(7):1988–2002. doi: 10.1016/j.celrep.2016.07.019
   PubMed Web of Science ®Google Scholar
• Cockram PE, Kist M, Prakash S, et al. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021 Feb;28(2):591–605. doi: 10.1038/s41418-020-00708-5
   PubMed Web of Science ®Google Scholar
• Khaminets A, Behl C, Dikic I. Ubiquitin-dependent and independent Signals in selective autophagy. Trends Cell Biol. 2016 Jan;26(1):6–16. doi: 10.1016/j.tcb.2015.08.010
   PubMed Web of Science ®Google Scholar
• Damgaard RB. The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities. Cell Death Differ. 2021 Feb;28(2):423–426. doi: 10.1038/s41418-020-00703-w
   PubMed Web of Science ®Google Scholar
• Schmidt MF, Gan ZY, Komander D, et al. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death Differ. 2021 Feb;28(2):570–590. doi: 10.1038/s41418-020-00706-7
   PubMed Web of Science ®Google Scholar
• Shi CS, Shenderov K, Huang NN, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012 Jan 29;13(3):255–263. doi: 10.1038/ni.2215
   PubMed Web of Science ®Google Scholar
• Walinda E, Morimoto D, Sugase K, et al. Solution structure of the ubiquitin-associated (UBA) domain of human autophagy receptor NBR1 and its interaction with ubiquitin and polyubiquitin. J Biol Chem. 2014 May 16;289(20):13890–13902. doi: 10.1074/jbc.M114.555441
   PubMed Web of Science ®Google Scholar
• Zhuang W, Zhang L, Zheng Y, et al. USP3 deubiquitinates and stabilizes the adapter protein ASC to regulate inflammasome activation. Cell Mol Immunol. 2022 Sep 1;19(10):1141–1152. doi: 10.1038/s41423-022-00917-7
   PubMed Web of Science ®Google Scholar
• Chiu HW, Chen CH, Chang JN, et al. Far-infrared promotes burn wound healing by suppressing NLRP3 inflammasome caused by enhanced autophagy. J Mol Med (Berl). 2016 Jul;94(7):809–819. doi: 10.1007/s00109-016-1389-0
   PubMed Web of Science ®Google Scholar
• Lee JY, Seo D, You J, et al. The deubiquitinating enzyme, ubiquitin-specific peptidase 50, regulates inflammasome activation by targeting the ASC adaptor protein. FEBS Lett. 2017 Feb;591(3):479–490. doi: 10.1002/1873-3468.12558
   PubMed Web of Science ®Google Scholar
• Chen Y, He H, Lin B, et al. Rrx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol. 2021 Jun;18(6):1425–1436. doi: 10.1038/s41423-021-00683-y
   PubMed Web of Science ®Google Scholar
• Ye Y, Scheel H, Hofmann K, et al. Dissection of USP catalytic domains reveals five common insertion points. Mol Biosyst. 2009 Dec;5(12):1797–1808. doi: 10.1039/b907669g
   PubMedGoogle Scholar
• Zhang H, Wang D, Zhong H, et al. Ubiquitin-specific protease 15 Negatively regulates Virus-induced type I Interferon signaling via Catalytically-dependent and -independent Mechanisms. Sci Rep. 2015 Jun 10;5(1):11220. doi: 10.1038/srep11220
   PubMedGoogle Scholar
• Sostres C, Gargallo CJ, Arroyo MT, et al. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010 Apr;24(2):121–132. doi: 10.1016/j.bpg.2009.11.005
   PubMed Web of Science ®Google Scholar
• Tong L, Nanjundaiah SM, Venkatesha SH, et al. Pristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage. Clin Immunol. 2014 Dec;155(2):220–230. doi: 10.1016/j.clim.2014.09.014
   PubMed Web of Science ®Google Scholar
• Chen RZ, Yang F, Zhang M, et al. Cellular and Molecular Mechanisms of Pristimerin in cancer therapy: Recent Advances. Front Oncol. 2021;11:671548. doi: 10.3389/fonc.2021.671548
   PubMed Web of Science ®Google Scholar
• Cevatemre B, Erkisa M, Aztopal N, et al. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. Pharmacol Res. 2018 Mar;129:500–514.
   PubMed Web of Science ®Google Scholar
• Lee Y, Na J, Lee MS, et al. Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation. Mol Med Rep. 2018 Nov;18(5):4281–4288. doi: 10.3892/mmr.2018.9488
   PubMed Web of Science ®Google Scholar
• Li JJ, Yan YY, Sun HM, et al. Anti-cancer effects of Pristimerin and the Mechanisms: A critical Review. Front Pharmacol. 2019;10:746. doi: 10.3389/fphar.2019.00746
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang J, Hui B, et al. Pristimerin enhances the effect of cisplatin by inhibiting the miR23a/Akt/GSK3beta signaling pathway and suppressing autophagy in lung cancer cells. Int J Mol Med. 2019 Mar;43(3):1382–1394. doi: 10.3892/ijmm.2019.4057
   PubMed Web of Science ®Google Scholar
• Huang D, Su L, He C, et al. Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-kappaB pathway. Biochem Cell Biol. 2022 Jun 1;100(3):223–235. doi: 10.1139/bcb-2021-0251
   PubMedGoogle Scholar
• Sharma M, de Alba E. Structure, activation and regulation of NLRP3 and AIM2 inflammasomes. Int J Mol Sci. 2021 Jan 16;22(2):872. doi: 10.3390/ijms22020872
   PubMed Web of Science ®Google Scholar
• Lin L, Shen Q, Xue T, et al. Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: expression of bone and cartilage related genes. Bone. 2010 Feb;46(2):425–431. doi: 10.1016/j.bone.2009.08.057
   PubMed Web of Science ®Google Scholar
• Jiang H, Chen Y, Chen G, et al. Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling. J Cell Physiol. 2018 Feb;233(2):1017–1028. doi: 10.1002/jcp.25955
   PubMed Web of Science ®Google Scholar
• Wang Y, He G, Tang H, et al. Aspirin promotes tenogenic differentiation of tendon stem cells and facilitates tendinopathy healing through regulating the GDF7/Smad1/5 signaling pathway. J Cell Physiol. 2020 May;235(5):4778–4789. doi: 10.1002/jcp.29355
   PubMed Web of Science ®Google Scholar
• Tan P, He L, Xing C, et al. Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development. J Clin Invest. 2019 Dec 2;129(12):5261–5277. doi: 10.1172/JCI127721
   PubMed Web of Science ®Google Scholar
• Stoll C, John T, Conrad C, et al. Healing parameters in a rabbit partial tendon defect following tenocyte/biomaterial implantation. Biomaterials. 2011 Jul;32(21):4806–4815. doi: 10.1016/j.biomaterials.2011.03.026
   PubMed Web of Science ®Google Scholar
• Chen Y, Li L, Wang E, et al. Abnormal expression of Pappa2 gene may indirectly affect mouse hip development through the IGF signaling pathway. Endocrine. 2019 Aug;65(2):440–450. doi: 10.1007/s12020-019-01975-0
   PubMed Web of Science ®Google Scholar
• Luan XR, Chen XL, Tang YX, et al. CRISPR/Cas9-mediated treatment ameliorates the phenotype of the epidermolytic palmoplantar keratoderma-like Mouse. Mol Ther Nucleic Acids. 2018 Sep 7;12:220–228. doi: 10.1016/j.omtn.2018.05.005
   PubMedGoogle Scholar
• Holmgaard A, Askou AL, Benckendorff JNE, et al. In vivo knockout of the vegfa gene by lentiviral delivery of crispr/cas9 in mouse retinal pigment epithelium cells. Mol Ther Nucleic Acids. 2017 Dec 15;9:89–99. doi: 10.1016/j.omtn.2017.08.016
   PubMedGoogle Scholar